Silo Pharma, Inc. also files under UCUT, PTCI; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 15, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 3K | $0.42 | $1K |
| Dec 15, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 3K | $0.41 | $1K |
| Nov 21, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 1K | $0.37 | $370 |
| Nov 20, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 1K | $0.37 | $370 |
| Nov 19, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 5K | $0.41 | $2K |
| Nov 18, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 8K | $0.40 | $3K |
| May 27, 2025 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 10K | $0.43 | $4K |
| May 23, 2025 | Pavell Jeff | Director | Grant(A) | 50K | — | $0 |
| May 23, 2025 | Weisblum Eric | Chief Executive Officer, Director | Grant(A) | 200K | — | $0 |
| May 23, 2025 | Ryweck Daniel E. | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| May 23, 2025 | Munoz Kevin | Director | Grant(A) | 50K | — | $0 |
| May 23, 2025 | Linsley Wayne | Director | Grant(A) | 50K | — | $0 |
| Dec 13, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 3K | $0.84 | $2K |
| Nov 22, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 3K | $0.90 | $2K |
| Nov 20, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 3K | $0.95 | $2K |
| Jun 12, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 4K | $1.11 | $5K |
| Jun 11, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 562 | $1.08 | $607 |
| Apr 5, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 400 | $2.03 | $812 |
| Apr 4, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 600 | $1.96 | $1K |
| Apr 1, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 1K | $1.91 | $2K |
| Mar 28, 2024 | Weisblum Eric | CEO and President, Director | Buy(P) | 3K | $1.94 | $7K |
| Dec 20, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 200 | $1.61 | $322 |
| Dec 19, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 500 | $1.63 | $815 |
| Dec 15, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 900 | $1.52 | $1K |
| Dec 14, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 200 | $1.50 | $300 |
| Dec 7, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 324 | $1.36 | $441 |
| Dec 6, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 76 | $1.34 | $102 |
| Dec 5, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 600 | $1.39 | $834 |
| Nov 30, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 1K | $1.53 | $2K |
| Nov 29, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 1K | $1.57 | $2K |
| Nov 27, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 250 | $1.78 | $445 |
| Nov 22, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 400 | $1.68 | $672 |
| Nov 21, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 300 | $1.56 | $468 |
| Nov 20, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 4K | $1.60 | $6K |
| Nov 17, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 2K | $1.54 | $3K |
| Nov 16, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 1K | $1.33 | $1K |
| May 26, 2023 | Ryweck Daniel E. | Chief Financial Officer | Buy(P) | 1K | $2.13 | $2K |
| May 18, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 500 | $2.11 | $1K |
| May 17, 2023 | Weisblum Eric | CEO and President, Director | Buy(P) | 3K | $2.06 | $5K |
| Dec 20, 2022 | Weisblum Eric | CEO and President, Director | Buy(P) | 130 | $2.72 | $354 |
| Dec 19, 2022 | Weisblum Eric | CEO and President, Director | Buy(P) | 200 | $2.68 | $536 |
| Dec 14, 2022 | Weisblum Eric | CEO and President, Director | Buy(P) | 263 | $3.17 | $834 |
| Dec 13, 2022 | Weisblum Eric | CEO and President, Director | Buy(P) | 487 | $3.07 | $1K |
| Jun 17, 2022 | Weisblum Eric | CEO, CFO and President, Director | Buy(P) | 13K | $0.11 | $1K |
| Dec 29, 2021 | Munoz Kevin | Director | Grant(A) | 171K | — | $0 |
| Dec 29, 2021 | Linsley Wayne | Director | Grant(A) | 171K | — | $0 |
| Dec 13, 2021 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 18K | $0.14 | $2K |
| Dec 10, 2021 | Weisblum Eric | Chief Executive Officer, Director | Buy(P) | 5K | $0.16 | $800 |
| Apr 28, 2020 | Weisblum Eric | CEO, CFO and President, Director | Grant(A) | 7.6M | — | — |
| Oct 22, 2019 | Weisblum Eric | CEO, CFO and President, Director | Buy(P) | 200 | $0.45as filed | — |
| Oct 15, 2019 | Weisblum Eric | CEO, CFO and President, Director | Grant(A) | 100K | — | $0 |
| Oct 15, 2019 | Weisblum Eric | CEO, CFO and President, Director | Buy(P) | 200 | $0.38as filed | — |
| Jun 17, 2019 | Weisblum Eric | CEO, CFO and President, Director | Buy(P) | 58K | — | $0 |
| Apr 15, 2019 | Weisblum Eric | CEO, CFO and President, Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2019 | Weisblum Eric | CEO, CFO and President, Director | Grant(A) | 100K | — | $0 |
| Feb 10, 2016 | Parker Van Eps | Director | Other(J) | 113K | — | — |
| Jan 1, 2015 | Stone, Joel Alan | Director | Other(J) | 113K | — | — |
| Jan 1, 2015 | Parker Walter Van Eps | Director | Other(J) | 113K | — | — |
| Jan 1, 2015 | Schiller Leonard M | Director | Other(J) | 113K | — | — |
| Sep 4, 2014 | Weisblum Eric | Pres, Chief Compliance Officer, Director | Gift(G) | 3.6M | $1.00 | $3.6M |
| Jul 30, 2014 | Parker Walter Van Eps | Director | Grant(A) | 38K | — | — |
| Jun 20, 2013 | Brand Richard | Chairman and CEO, Director | Grant(A) | 2.0M | — | — |
| Jun 20, 2013 | Weisblum Eric | President and CCO, Director | Grant(A) | 3.6M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Silo Pharma, Inc., SEC CIK 0001514183. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SILO and shows every filing by that issuer (also filed as UCUT, PTCI).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SILO